Giulio Francolini, Filippo Alongi, Andrea Gaetano Allegra, Andrea Romei, Francesco Cuccia, Giuseppe Ferrera, Fabio Matrone, Nicola Simoni, Alessio Bruni, Luca Tagliaferri, Stefano Pergolizzi, Ciro Franzese, Giuseppe Carlo Iorio, Matteo Augugliaro, Ivan Fazio, Rosario Mazzola, Michele Aquilano, Niccolò Bertini, Francesco Micciche, Lorenzo Livi. "Ultra-hypofractionated radiotherapy and concomitant oral relugolix for treatment of intermediate risk prostate cancer (ULTRA-HERO).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps411